Key points are not available for this paper at this time.
These findings suggested that LPCAT1 may act as a valuable prognostic biomarker and be correlated with immune infiltrates in endometrial cancer, which may provide novel therapy options for and improved treatment of EC.
Zhao et al. (Thu,) studied this question.